Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of UBQLN2 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | WB-Ce |
More info about UBQLN2 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB1699 |
| Product name: | UBQLN2 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of UBQLN2. |
| Gene id: | 29978 |
| Gene name: | UBQLN2 |
| Gene alias: | CHAP1|CHAP1/DSK2|Dsk2|HRIHFB2157|LIC-2|N4BP4|PLIC-2|PLIC2|RIHFB2157 |
| Gene description: | ubiquilin 2 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human UBQLN2. |
| Protein accession: | Q9UHD9 |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:1000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | The UBQLN2 polyclonal antibody (Cat # PAB1699) is used in Western blot to detect UBQLN2 in HeLa cell lysate. |
| Applications: | WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome.Kleijnen MF, Shih AH, Zhou P, Kumar S, Soccio RE, Kedersha NL, Gill G, Howley PM. Mol Cell. 2000 Aug;6(2):409-19. |